These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 3542653)
41. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial. Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323 [TBL] [Abstract][Full Text] [Related]
42. Insulin antibodies do not influence the absorption rate of subcutaneously injected insulin. de Meijer PH; Lutterman JA; van't Laar A Diabet Med; 1988 Nov; 5(8):776-81. PubMed ID: 2975571 [TBL] [Abstract][Full Text] [Related]
43. Effects of a somatostatin derivative (SMS 201-995) on postprandial hyperglycemia in insulin-dependent diabetics studied by means of a closed-loop device. Nosari I; Lepore G; Querci F; Maglio ML; Sileo F; Pagani G J Endocrinol Invest; 1989 Jun; 12(6):413-7. PubMed ID: 2671112 [TBL] [Abstract][Full Text] [Related]
44. Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type I diabetic patients. Vuorinen-Markkola H; Koivisto VA; Yki-Jarvinen H Diabetes; 1992 May; 41(5):571-80. PubMed ID: 1568526 [TBL] [Abstract][Full Text] [Related]
46. Insulin secretion and anti-GAD65 antibodies in subjects with impaired glucose tolerance. Tankova T; Dakovska L; Kirilov G; Koev D Exp Clin Endocrinol Diabetes; 2001; 109(7):355-60. PubMed ID: 11573145 [TBL] [Abstract][Full Text] [Related]
47. Effects of thorough mastication on postprandial plasma glucose concentrations in nonobese Japanese subjects. Suzuki H; Fukushima M; Okamoto S; Takahashi O; Shimbo T; Kurose T; Yamada Y; Inagaki N; Seino Y; Fukui T Metabolism; 2005 Dec; 54(12):1593-9. PubMed ID: 16311091 [TBL] [Abstract][Full Text] [Related]
48. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Bruttomesso D; Pianta A; Mari A; Valerio A; Marescotti MC; Avogaro A; Tiengo A; Del Prato S Diabetes; 1999 Jan; 48(1):99-105. PubMed ID: 9892228 [TBL] [Abstract][Full Text] [Related]
49. Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin. de Meijer PH; Lutterman JA Neth J Med; 1990 Feb; 36(1-2):4-12. PubMed ID: 2179752 [TBL] [Abstract][Full Text] [Related]
50. Effects of physical exercise on insulin absorption in insulin-dependent diabetics. A comparison between human and porcine insulin. Fernqvist E; Linde B; Ostman J; Gunnarsson R Clin Physiol; 1986 Dec; 6(6):489-97. PubMed ID: 3539462 [TBL] [Abstract][Full Text] [Related]
51. Effects of a palatinose-based liquid diet (Inslow) on glycemic control and the second-meal effect in healthy men. Arai H; Mizuno A; Sakuma M; Fukaya M; Matsuo K; Muto K; Sasaki H; Matsuura M; Okumura H; Yamamoto H; Taketani Y; Doi T; Takeda E Metabolism; 2007 Jan; 56(1):115-21. PubMed ID: 17161233 [TBL] [Abstract][Full Text] [Related]
52. First-phase insulin secretion has limited impact on postprandial glycemia in subjects with type 2 diabetes: correlations between hyperglycemic glucose clamp and meal test. Rave K; Sidharta PN; Dingemanse J; Heinemann L; Roggen K Diabetes Technol Ther; 2010 Feb; 12(2):117-23. PubMed ID: 20105041 [TBL] [Abstract][Full Text] [Related]
53. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model. Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971 [TBL] [Abstract][Full Text] [Related]
54. Pre- and postprandial hyperinsulinemia during insulin pump treatment; role of the subcutaneous bolus and basal infusion. Olsson PO; Jorfeldt L; Arnqvist H; Gerhardsson P Diabetes Res; 1991 Feb; 16(2):55-61. PubMed ID: 1817806 [TBL] [Abstract][Full Text] [Related]
55. Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM. Gutniak MK; Linde B; Holst JJ; Efendić S Diabetes Care; 1994 Sep; 17(9):1039-44. PubMed ID: 7988303 [TBL] [Abstract][Full Text] [Related]
57. Postprandial glucose, insulin and incretin responses to different carbohydrate tolerance tests. Deng Y; Zhang Y; Zheng S; Hong J; Wang C; Liu T; Sun Z; Gu W; Gu Y; Shi J; Yao S; Wang W; Ning G J Diabetes; 2015 Nov; 7(6):820-9. PubMed ID: 25395350 [TBL] [Abstract][Full Text] [Related]
58. Effect of insulin antibodies and their kinetic characteristics on plasma free insulin dynamics in patients with diabetes mellitus. Van Haeften TW; Bolli GB; Dimitriadis GD; Gottesman IS; Horwitz DL; Gerich JE Metabolism; 1986 Jul; 35(7):649-56. PubMed ID: 3523119 [TBL] [Abstract][Full Text] [Related]
59. Preprandial blood glucose values and glycemic responses in insulin-dependent diabetes mellitus at constant insulinemia. Rasmussen O; Hermansen K Am J Clin Nutr; 1991 Feb; 53(2):520-3. PubMed ID: 1989420 [TBL] [Abstract][Full Text] [Related]
60. The pharmacokinetics of subcutaneous regular insulin in type I diabetic patients: assessment using a glucose clamp technique. Gardner DF; Arakaki RF; Podet EJ; Nell LJ; Thomas JW; Field JB J Clin Endocrinol Metab; 1986 Sep; 63(3):689-94. PubMed ID: 3525600 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]